Schedule of Business Acquisitions (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 01, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Business Acquisition [Line Items] | |||
| Preliminary goodwill | $ 1,128,000 | $ 311,000 | |
| Kenkoderm Acquisition [Member] | |||
| Business Acquisition [Line Items] | |||
| Cash contributed by the Company | $ 546,500 | ||
| Noncontrolling interest portion of CG Labs contributed business | 439,000 | ||
| Consideration paid | 986,000 | ||
| Inventory | 56,000 | ||
| Product/Technology related intangibles | 77,000 | ||
| Marketing related intangibles | 36,000 | ||
| Other liabilities | |||
| Total net assets acquired | 169,000 | ||
| Preliminary goodwill | $ 817,000 | ||
| CG Labs [Member] | |||
| Business Acquisition [Line Items] | |||
| Cash contributed by the Company | 500,000 | ||
| Noncontrolling interest portion of CG Labs contributed business | 500,000 | ||
| Consideration paid | 1,000,000 | ||
| Product/Technology related intangibles | 217,000 | ||
| Marketing related intangibles | 70,000 | ||
| Total net assets acquired | 1,000,000 | ||
| Preliminary goodwill | |||
| Fixed assets | $ 213,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of inventory recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|